WINT Research and Charts

WINT - Windtree Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-03)

Last 0.32	Change ⇓ -0.02 (0.00%)	Volume 8,291,428
	Open 0.34	High 0.36	Low 0.31

8EMA (Daily) 0.33	40EMA (Daily) 0.61	50EMA (Daily) 0.81	STO (Daily) 27.692	MACD Hist (Daily) 0.058
8EMA (Weekly) 0.538	40EMA (Weekly) 7.00	50EMA (Weekly) 15.30	STO (Weekly) 0.554	MACD Hist (Weekly) 0.970


Company Profile
Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes a synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactant without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF that is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.